Skip to main content
Purple Biotech Ltd. logo

Purple Biotech Ltd. — Investor Relations & Filings

Ticker · PPBT ISIN · IL0007650166 TA Manufacturing
Filings indexed 1,071 across all filing types
Latest filing 2026-03-17 Regulatory Filings
Country IL Israel
Listing TA PPBT

About Purple Biotech Ltd.

https://purple-biotech.com/

Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.

Recent filings

Filing Released Lang Actions
Purple Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by Purple Biotech Ltd. The primary content is an announcement regarding the company regaining compliance with Nasdaq's minimum bid price requirement. While it is a regulatory filing, it does not fit into specific categories like financial reports, M&A, or governance. As it is a general regulatory announcement regarding listing status, it falls under the RNS (Regulatory Filings) category.
2026-03-17 English
Purple Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement
Report Publication Announcement Classification · 95% confidence The document is a short filing (2088 characters) submitted to the Israel Securities Authority (MAGNA system). It explicitly states 'Attached hereto is a report on...' followed by a title regarding NASDAQ compliance. According to the 'Menu vs Meal' rule, a short document that announces the attachment of another report is classified as a Report Publication Announcement (RPA).
2026-03-17 English
Other Report or Announcement
Board/Management Information Classification · 100% confidence The document is a press release announcing a CEO transition at Purple Biotech, where the current CEO, Gil Efron, will step down in August 2026. It details the leadership change, the search for a successor, and the transition of the current CEO to a new role within the company. This falls squarely under the category of announcements regarding changes in senior management.
2026-03-13 English
Other Report or Announcement
Report Publication Announcement Classification · 95% confidence The document is a short regulatory filing from Purple Biotech Ltd submitted via the MAGNA system. It explicitly states 'Attached hereto is a report on' followed by the Hebrew text 'פרפל ביוטק מודיעה על חילופי מנכ״ל', which translates to 'Purple Biotech announces a change of CEO'. Since the document is a brief notification announcing that a report regarding management changes is attached, it falls under the Report Publication Announcement (RPA) category.
2026-03-13 English
Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results
Earnings Release Classification · 100% confidence The document is a press release issued by Purple Biotech announcing its financial results for the fourth quarter and full year ended December 31, 2025. It contains key financial highlights, management commentary, and summary financial tables. This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodic financial results rather than the full, comprehensive Annual Report (10-K). Q4 2025
2026-03-13 English
Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results
Report Publication Announcement Classification · 95% confidence The document is a short notification from Purple Biotech Ltd filed via the Israel Securities Authority (MAGNA system). It explicitly states 'Attached hereto is a report on...' followed by the title of the financial results report. Because the document is short (2105 characters) and serves as a cover notice announcing the availability of an attached financial report, it falls under the 'Report Publication Announcement' (RPA) category according to the 'Menu vs Meal' rule.
2026-03-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.